title: Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice.
abstract: Approaches targeting nitric oxide (NO) signaling show promise as therapies for Duchenne and Becker muscular dystrophies. However, the mechanisms by which NO benefits dystrophin-deficient muscle remain unclear, but may involve nNOSβ, a newly discovered enzymatic source of NO in skeletal muscle. Here we investigate the impact of dystrophin deficiency on nNOSβ and use mdx mice engineered to lack nNOSμ and nNOSβ to discern how the loss of nNOS impacts dystrophic skeletal muscle pathology. In mdx muscle, nNOSβ was mislocalized and its association with the Golgi complex was reduced. nNOS depletion from mdx mice prevented compensatory skeletal muscle cell hypertrophy, decreased myofiber central nucleation and increased focal macrophage cell infiltration, indicating exacerbated dystrophic muscle damage. Reductions in muscle integrity in nNOS-null mdx mice were accompanied by decreases in specific force and increased susceptibility to eccentric contraction-induced muscle damage compared with mdx controls. Unexpectedly, muscle fatigue was unaffected by nNOS depletion, revealing a novel latent compensatory mechanism for the loss of nNOS in mdx mice. Together with previous studies, these data suggest that localization of both nNOSμ and nNOSβ is disrupted by dystrophin deficiency. They also indicate that nNOS has a more complex role as a modifier of dystrophic pathology and broader therapeutic potential than previously recognized. Importantly, these findings also suggest nNOSβ as a new drug target and provide a new conceptual framework for understanding nNOS signaling and the benefits of NO therapies in dystrophinopathies.
authors.affiliation: Department of Physiology and Biophysics, University of Washington Medical School, Seattle, WA, USA.
authors.forename: Stanley C
authors.initials: SC
authors.lastname: Froehner
authors.affiliation: Department of Physiology and Biophysics, University of Washington Medical School, Seattle, WA, USA.
authors.forename: Sarah M
authors.initials: SM
authors.lastname: Reed
authors.affiliation: Department of Physiology and Biophysics, University of Washington Medical School, Seattle, WA, USA.
authors.forename: Kendra N
authors.initials: KN
authors.lastname: Anderson
authors.affiliation: Cardiovascular Research Center and Harvard Stem Cell Institute, Massachusetts General Hospital, Boston, MA, USA and.
authors.forename: Paul L
authors.initials: PL
authors.lastname: Huang
authors.affiliation: Department of Physiology and Biophysics, University of Washington Medical School, Seattle, WA, USA Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, USA j.percival@med.miami.edu.
authors.forename: Justin M
authors.initials: JM
authors.lastname: Percival
mesh_terms: D000818:Animals; D016189:Dystrophin / Q000235:genetics / Q000378:metabolism; D006056:Golgi Apparatus / Q000201:enzymology; D006801:Humans; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018101:Mice, Inbred mdx; D018345:Mice, Knockout; D009119:Muscle Contraction; D018482:Muscle, Skeletal / Q000201:enzymology / Q000276:immunology / Q000503:physiopathology; D020388:Muscular Dystrophy, Duchenne / Q000201:enzymology* / Q000235:genetics / Q000276:immunology* / Q000503:physiopathology; D052248:Nitric Oxide Synthase Type I / Q000235:genetics / Q000378:metabolism*
chemical_list: D016189:Dystrophin; D052248:Nitric Oxide Synthase Type I; C496321:Nos1 protein, mouse